Literature DB >> 23428871

Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.

Tatiana Erazo1, Ana Moreno, Gerard Ruiz-Babot, Arantza Rodríguez-Asiain, Nicholas A Morrice, Josep Espadamala, Jose R Bayascas, Nestor Gómez, Jose M Lizcano.   

Abstract

The mitogen-activated protein (MAP) kinase extracellular signal-regulated kinase 5 (ERK5) plays a crucial role in cell proliferation, regulating gene transcription. ERK5 has a unique C-terminal tail which contains a transcriptional activation domain, and activates transcription by phosphorylating transcription factors and acting itself as a transcriptional coactivator. However, the molecular mechanisms that regulate its nucleocytoplasmatic traffic are unknown. We have used tandem affinity purification to identify proteins that interact with ERK5. We show that ERK5 interacts with the Hsp90-Cdc37 chaperone in resting cells, and that inhibition of Hsp90 or Cdc37 results in ERK5 ubiquitylation and proteasomal degradation. Interestingly, activation of cellular ERK5 induces Hsp90 dissociation from the ERK5-Cdc37 complex, leading to ERK5 nuclear translocation and activation of transcription, by a mechanism which requires the autophosphorylation at its C-terminal tail. Consequently, active ERK5 is no longer sensitive to Hsp90 or Cdc37 inhibitors. Cdc37 overexpression also induces Hsp90 dissociation and the nuclear translocation of a kinase-inactive form of ERK5 which retains transcriptional activity. This is the first example showing that ERK5 transcriptional activity does not require kinase activity. Since Cdc37 cooperates with ERK5 to promote cell proliferation, Cdc37 overexpression (as happens in some cancers) might represent a new, noncanonical mechanism by which ERK5 regulates tumor proliferation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428871      PMCID: PMC3624243          DOI: 10.1128/MCB.01246-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

Review 1.  Targeting the oncogene and kinome chaperone CDC37.

Authors:  Phillip J Gray; Thomas Prince; Jinrong Cheng; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Nat Rev Cancer       Date:  2008-05-30       Impact factor: 60.716

2.  Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation.

Authors:  Hiroko Morimoto; Kunio Kondoh; Satoko Nishimoto; Kazuya Terasawa; Eisuke Nishida
Journal:  J Biol Chem       Date:  2007-10-10       Impact factor: 5.157

3.  The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues.

Authors:  L Stepanova; M Finegold; F DeMayo; E V Schmidt; J W Harper
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia.

Authors:  L Stepanova; G Yang; F DeMayo; T M Wheeler; M Finegold; T C Thompson; J W Harper
Journal:  Oncogene       Date:  2000-04-27       Impact factor: 9.867

5.  Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation.

Authors:  M Chiariello; M J Marinissen; J S Gutkind
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.

Authors:  Larissa Belova; Deanna R Brickley; Betty Ky; Sanjay K Sharma; Suzanne D Conzen
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

7.  A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.

Authors:  Tao Zhang; Adel Hamza; Xianhua Cao; Bing Wang; Shuwen Yu; Chang-Guo Zhan; Duxin Sun
Journal:  Mol Cancer Ther       Date:  2008-01       Impact factor: 6.261

8.  Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer.

Authors:  S R C McCracken; A Ramsay; R Heer; M E Mathers; B L Jenkins; J Edwards; C N Robson; R Marquez; P Cohen; H Y Leung
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

9.  Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90.

Authors:  Michael Hinz; Meike Broemer; Seda Cöl Arslan; Albrecht Otto; Eva-Christina Mueller; Rudolf Dettmer; Claus Scheidereit
Journal:  J Biol Chem       Date:  2007-08-29       Impact factor: 5.157

10.  Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.

Authors:  Phillip J Gray; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

View more
  28 in total

Review 1.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

Review 2.  Oncogenic signaling of MEK5-ERK5.

Authors:  Van T Hoang; Thomas J Yan; Jane E Cavanaugh; Patrick T Flaherty; Barbara S Beckman; Matthew E Burow
Journal:  Cancer Lett       Date:  2017-01-30       Impact factor: 8.679

3.  Nuclear ERK5 inhibits progression of leukemic monocytes to macrophages by regulating the transcription factor PU.1 and heat shock protein HSP70.

Authors:  Ruifang Zheng; George P Studzinski
Journal:  Leuk Lymphoma       Date:  2016-10-17

4.  Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.

Authors:  Fabrice Jaffré; Clint L Miller; Anne Schänzer; Todd Evans; Amy E Roberts; Andreas Hahn; Maria I Kontaridis
Journal:  Circulation       Date:  2019-06-05       Impact factor: 29.690

5.  The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.

Authors:  Xuening Wang; Stella Pesakhov; Jonathan S Harrison; Michael Kafka; Michael Danilenko; George P Studzinski
Journal:  Exp Cell Res       Date:  2014-10-16       Impact factor: 3.905

6.  A mitochondrial contribution to anti-inflammatory shear stress signaling in vascular endothelial cells.

Authors:  Brian G Coon; Sushma Timalsina; Matteo Astone; Zhen W Zhuang; Jennifer Fang; Jinah Han; Jurgen Themen; Minhwan Chung; Young Joo Yang-Klingler; Mukesh Jain; Karen K Hirschi; Ai Yamamato; Louis-Eric Trudeau; Massimo Santoro; Martin A Schwartz
Journal:  J Cell Biol       Date:  2022-06-13       Impact factor: 8.077

Review 7.  ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells.

Authors:  Xuening Wang; Stella Pesakhov; Ashley Weng; Michael Kafka; Elzbieta Gocek; Mai Nguyen; Jonathan S Harrison; Michael Danilenko; George P Studzinski
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-26       Impact factor: 4.292

8.  Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains.

Authors:  Jinhua Wang; Tatiana Erazo; Fleur M Ferguson; Dennis L Buckley; Nestor Gomez; Pau Muñoz-Guardiola; Nora Diéguez-Martínez; Xianming Deng; Mingfeng Hao; Walter Massefski; Oleg Fedorov; Nana Kwaku Offei-Addo; Paul M Park; Lingling Dai; Amy DiBona; Kelly Becht; Nam Doo Kim; Michael R McKeown; Justin M Roberts; Jinwei Zhang; Taebo Sim; Dario R Alessi; James E Bradner; Jose M Lizcano; Stephen C Blacklow; Jun Qi; Xiang Xu; Nathanael S Gray
Journal:  ACS Chem Biol       Date:  2018-08-31       Impact factor: 5.100

9.  Quantitative proteomics of the yeast Hsp70/Hsp90 interactomes during DNA damage reveal chaperone-dependent regulation of ribonucleotide reductase.

Authors:  Andrew W Truman; Kolbrun Kristjansdottir; Donald Wolfgeher; Natalia Ricco; Anoop Mayampurath; Samuel L Volchenboum; Josep Clotet; Stephen J Kron
Journal:  J Proteomics       Date:  2014-10-18       Impact factor: 4.044

10.  The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells.

Authors:  Pau Muñoz-Guardiola; Josefina Casas; Elisabet Megías-Roda; Sònia Solé; Héctor Perez-Montoyo; Marc Yeste-Velasco; Tatiana Erazo; Nora Diéguez-Martínez; Sergio Espinosa-Gil; Cristina Muñoz-Pinedo; Guillermo Yoldi; Jose L Abad; Miguel F Segura; Teresa Moran; Margarita Romeo; Joaquim Bosch-Barrera; Ana Oaknin; Jose Alfón; Carles Domènech; Gemma Fabriàs; Guillermo Velasco; Jose M Lizcano
Journal:  Autophagy       Date:  2020-05-25       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.